4-(2’-吡啶基)苯甲酸 | 4385-62-0

• 物质功能分类: 医药中间体 - 原料药中间体
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 4-(2’-吡啶基)苯甲酸
• 中文别名: 4-(2'-吡啶基)苯甲酸；4-(2-吡啶基)苯甲酸；4-(吡啶-2-基)苯甲酸
• 英文名称: 2-(4-carboxyphenyl)pyridine
• 英文别名: 4-(pyridin-2-yl)benzoic acid；4-pyridin-2-ylbenzoic acid
• CAS: 4385-62-0
• 化学式: C₁₂H₉NO₂
• 分子量: 199.209
• InChiKey: AQIPNZHMXANQRC-UHFFFAOYSA-N

物化性质

• 熔点：
  236.0 to 240.0 °C
• 沸点：
  388.1±25.0 °C(Predicted)
• 密度：
  1.241±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于DMSO（轻微）、甲醇（轻微、加热）
• 稳定性/保质期：
  在常温常压下保持稳定

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  50.2
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• WGK Germany：
  3
• 海关编码：
  2933399090
• 安全说明：
  S23,S24/25
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  请将药品存放在避光、通风干燥的地方，并密封保存。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-(2-Pyridyl)benzoic acid
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-(2-Pyridyl)benzoic acid
CAS number: 4385-62-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H9NO2
Molecular weight: 199.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-(2’-吡啶基)苯甲酸 在 盐酸 、 甲醇 作用下， 生成 4-(2-吡啶基)-苯甲酸甲酯
  参考文献：
  名称：

  Butterworth et al., Journal of the Chemical Society, 1940, p. 355,357

  摘要：

  DOI：
• 作为产物：
  描述：

  4-(2-吡啶基)-苯甲酸甲酯 在 乙酸乙酯 、 title compound 、 水 作用下， 以 甲醇 、 sodium hydroxide 为溶剂， 反应 6.0h， 生成 4-(2’-吡啶基)苯甲酸
  参考文献：
  名称：

  Intermediates for the preparation of peptide analogues

  摘要：

  本发明涉及一种制备式I化合物的新型方法：##STR1## 其中R.sub.1为氢或适当的氨基保护基，R.sub.2为未取代或取代的烷基，R.sub.3为氢、芳基、杂环基、未取代或取代的烷基或未取代或取代的环烷基，R.sub.4，独立于R.sub.1，为氢或适当的氨基保护基，m为1至7的数字；并且还可以存在适当的保护基用于功能基团；这些化合物具有抗病毒活性或可用作制药活性物质，特别是抗病毒化合物的起始材料。前体是一个酮化合物，该酮化合物又通过与适当的复合物氢化物或在适当催化剂存在下与氢反应并且从一个腙酮开始的酰基迁移制备而成，该腙酮优选地是通过从腈经由亚胺化合物的氢化和与一个肼衍生物的反应制备而成，该肼衍生物是通过在腈盐存在下与羧酸的反应性衍生物的反应制备而成，该羧酸衍生物是由醛与氰盐反应制备而成；以及所需的新型中间体。

  公开号：

  US05912352A1
• 作为试剂：
  描述：

  4-羧基苯硼酸 、 2-溴吡啶 、 potassium carbonate 在 双三苯基磷二氯化钯 二氯甲烷 、 水 、 4-(2’-吡啶基)苯甲酸 作用下， 以 乙腈 、 水 为溶剂， 反应 24.0h， 以to obtain 1.81 g of white solid of 4-(pyridin-2-yl)benzoic acid的产率得到4-(2’-吡啶基)苯甲酸
  参考文献：
  名称：

  BENZOXAZOLE CARBOXAMIDE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP)

  摘要：

  一种具有以下式子（I）或式子（II）结构的化合物：其中变量Y，R1，R2，R3和R4如本文所定义。本文提供了聚(ADP-核糖)聚合酶活性抑制剂。本文还描述了包括至少一种本文所述化合物的制药组合物，以及使用本文所述的化合物或制药组合物来治疗通过抑制PARP活性改善的疾病，障碍和病况。

  公开号：

  US20090197863A1

文献信息

• Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists
  申请人：Failli A. Amedeo

  公开号：US20060287522A1

  公开（公告）日：2006-12-21

  This invention provides pyrrolobenzodiazepine pyridine carboxamides selected from those of Formula (1), which act as follicle stimulating hormone receptor antagonists. The invention also provides pharmaceutical compositions and methods of treatment utilizing the compounds of Formulae (1) and (2).

  这项发明提供了从式（1）中选择的吡咯苯并二氮杂吡咯烷吡啶羧酰胺，其作为卵泡刺激素受体拮抗剂。该发明还提供了利用式（1）和（2）化合物的药物组合物和治疗方法。
• Certain pyrazoline derivatives with kinase inhibitory activity
  申请人：Adams Ruth S.

  公开号：US20080171754A1

  公开（公告）日：2008-07-17

  The present invention provides certain pyrazoline compounds useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions and methods of using the compositions in the treatment of various diseases.

  本发明提供了某些吡唑啉化合物，可用作蛋白激酶的抑制剂。该发明还提供了药物组合物和使用这些组合物治疗各种疾病的方法。
• Diamine derivatives
  申请人：Ohta Toshiharu

  公开号：US20050020645A1

  公开（公告）日：2005-01-27

  A compound represented by the general formula (1): Q 1 -Q 2 -T 0 -N(R 1 )-Q 3 -N(R 2 )-T 1 -Q 4 (1) wherein R 1 and R 2 are hydrogen atoms or the like; Q 1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q 2 is a single bond or the like; Q 3 is a group in which Q 5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T 0 and T 1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.

  通用式（1）表示的化合物： Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4（1） 其中R1和R2是氢原子或类似物；Q1是饱和或不饱和的、5-或6-成员环烃基，可以被取代，或类似物；Q2是单键或类似物；Q3是一个基团，其中Q5是具有1至8个碳原子的烷基基团，或类似物；T0和T1是羰基团或类似物；其盐、溶剂合物或N-氧化物。 该化合物可用作预防和/或治疗脑梗死、脑栓塞、心肌梗死、心绞痛、肺梗死、肺栓塞、布尔格病、深静脉血栓形成、弥散性血管内凝血综合征、瓣膜或关节置换后的血栓形成、血管成形术后的血栓形成和再闭塞、全身性炎症反应综合征（SIRS）、多器官功能障碍综合征（MODS）、体外循环期间的血栓形成，或抽血时的血液凝结。
• Antivirally active heterocyclic azahexane derivatives
  申请人：Novartis Finance Corporation

  公开号：US05849911A1

  公开（公告）日：1998-12-15

  There are described compounds of formula I*, ##STR1## wherein R.sub.1 is lower alkoxycarbonyl, R.sub.2 is secondary or tertiary lower alkyl or lower alkylthio-lower alkyl, R.sub.3 is phenyl that is unsubstituted or substituted by one or more lower alkoxy radicals, or C.sub.4 -C.sub.8 cycloalkyl, R.sub.4 is phenyl or cyclohexyl each substituted in the 4-position by unsaturated heterocyclyl that is bonded by way of a ring carbon atom, has from 5 to 8 ring atoms, contains from 1 to 4 hetero atoms selected from nitrogen, oxygen, sulfur, sulfinyl (--SO--) and sulfonyl (--SO.sub.2 --) and is unsubstituted or substituted by lower alkyl or by phenyl-lower alkyl, R.sub.5, independently of R.sub.2, has one of the meanings mentioned for R.sub.2, and R.sub.6, independently of R.sub.1, is lower alkoxycarbonyl, or salts thereof, provided that at least one salt-forming group is present. The compounds are inhibitors of retroviral aspartate protease and can be used, for example, in the treatment of AIDS. They exhibit outstanding pharmacodynamic properties.

  以下是公式I*的描述，##STR1## 其中R.sub.1是低级烷氧羰基，R.sub.2是二级或三级低级烷基或低级烷基硫基-低级烷基，R.sub.3是未取代或由一个或多个低级烷氧基团取代的苯基，或者是C.sub.4 -C.sub.8环烷基，R.sub.4是苯基或环己基，每个在4位上取代有不饱和杂环，该杂环通过环碳原子连接，具有5到8个环原子，含有1到4个选自氮、氧、硫、亚磺酰基(--SO--)和磺酰基(--SO.sub.2--)的杂原子，并且未取代或由低级烷基或苯基-低级烷基取代，R.sub.5独立于R.sub.2，具有R.sub.2所述的一个含义，而R.sub.6独立于R.sub.1，是低级烷氧羰基，或其盐类，前提是至少存在一个成盐基团。这些化合物是逆转录病毒天冬氨酸蛋白酶的抑制剂，例如，可以用于治疗艾滋病。它们展现出卓越的药效动力学特性。
• Ammonia as Ultimate Amino Source in Synthesis of Primary Amines via Nickel-Promoted C–H Bond Amination
  作者：Lin Yu、Chan Yang、Yongqi Yu、Da Liu、Liang Hu、Yuanjiu Xiao、Ze-Nan Song、Ze Tan

  DOI：10.1021/acs.orglett.9b01968

  日期：2019.7.19

  The direct use of ammonia in transition-metal promoted C–H bond amination for the synthesis of primary amines is considered to be one of the major challenges in synthetic organic chemistry. Herein, we report that such transformation can be successfully achieved via nickel-promoted amination of inert arene C–H bonds with ammonia gas assisted by an 8-amino-quinoline directing group.

  在过渡金属促进的C–H键胺化反应中直接使用氨水合成伯胺被认为是合成有机化学的主要挑战之一。在本文中，我们报告说，这种转化可以通过镍促进的惰性芳烃CH键与8-氨基-喹啉导向基团辅助的氨气胺化而成功实现。